Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
A groundbreaking injectable therapy, NOV-101 (a neoantigen-targeted CAR-T cell therapy), has shown unprecedented tumor eradication in early-stage trials for advanced melanoma and non-small cell lung cancer (NSCLC). Developed by OncoVax ... Read More
Continuous Coverage
Here’s the rewritten, verified, and optimized article based on the provided guidelines: The high-stakes world of competitive chess…
Eugene, OR — Oregon’s baseball program made history Saturday night, securing a dramatic 6-5 victory over rival Oregon…
In the coastal town of Nettuno, the air smells of salt and pine, but for the past century,…
The Ulsan Dong-gu Family Center recently concluded a specialized communication workshop for local couples, aiming to resolve chronic…
Archaeological findings in the Braunschweiger Land reveal Bronze Age amber trade networks, prompting renewed interest in historical commerce’s…
Ukrainian President Zelenskyy urges U.S. Approval of a major drone deal, pending Trump’s signature, as Russia escalates threats.…
Global Affairs
The global cryptocurrency trading landscape is undergoing a seismic shift as traders increasingly gravitate toward platforms that prioritize…
Markets And Money
Slovakian media personality Jana Kirschner has publicly confirmed her relationship with Martin Ristovecký, a businessman and former political…
Digital Culture
Google has deployed an interactive quiz built via Google AI Studio to gamify the developer takeaways from I/O…
Science And Wellbeing
This article provides evidence-based guidelines on safe anal sexual practices, emphasizing hygiene, communication, and medical considerations to minimize…
Screen And Sound
Kiki Gyan’s long-awaited documentary, *Kiki Gyan: The Highlife of a Legend*, will premiere at this year’s Locarno Open…
Fixtures And Form
At 15, Vaibhav Sooryavanshi became the youngest IPL player to win a car at the 2026 awards, but…
